{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:08:26Z","timestamp":1793279306728,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02335-8","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T10:02:47Z","timestamp":1614506567000},"page":"3208-3223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treadmill Exercise Alleviates Brain Iron Dyshomeostasis Accelerating Neuronal Amyloid-\u03b2 Production, Neuronal Cell Death, and Cognitive Impairment in Transgenic Mice Model of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Dong-Hun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Chun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Joo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hoon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Seob","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Sun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-0172","authenticated-orcid":false,"given":"Yongchul","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"issue":"7000","key":"2335_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430(7000):631\u2013639. https:\/\/doi.org\/10.1038\/nature02621","journal-title":"Nature"},{"issue":"2","key":"2335_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741\u2013766. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.741","journal-title":"Physiol Rev"},{"issue":"4","key":"2335_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362(4):329\u2013344. https:\/\/doi.org\/10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"issue":"5","key":"2335_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/mp.2008.96","volume":"14","author":"KA Bates","year":"2009","unstructured":"Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN (2009) Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry 14(5):469\u2013486. https:\/\/doi.org\/10.1038\/mp.2008.96","journal-title":"Mol Psychiatry"},{"issue":"10","key":"2335_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768\u2013778. https:\/\/doi.org\/10.1038\/nrn2494","journal-title":"Nat Rev Neurosci"},{"key":"2335_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S et al (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol 8:9. https:\/\/doi.org\/10.1186\/1471-2377-8-9","journal-title":"BMC Neurol"},{"issue":"3","key":"2335_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neurobiolaging.2004.08.005","volume":"26","author":"IT Lott","year":"2005","unstructured":"Lott IT, Head E (2005) Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol Aging 26(3):383\u2013389. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.08.005","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2335_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tan L, Yu JT, Tan L (2018) Tau in Alzheimer's disease: mechanisms and therapeutic strategies. Curr Alzheimer Res 15(3):283\u2013300. https:\/\/doi.org\/10.2174\/1567205014666170417111859","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 5","key":"2335_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1289\/ehp.98106s51241","volume":"106 Suppl 5","author":"CE Cross","year":"1998","unstructured":"Cross CE, van der Vliet A, Louie S, Thiele JJ, Halliwell B (1998) Oxidative stress and antioxidants at biosurfaces: plants, skin, and respiratory tract surfaces. Environ Health Perspect 106 Suppl 5(Suppl 5):1241\u20131251. https:\/\/doi.org\/10.1289\/ehp.98106s51241","journal-title":"Environ Health Perspect"},{"key":"2335_CR10","doi-asserted-by":"publisher","unstructured":"Ang ET, Tai YK, Lo SQ, Seet R, Soong TW (2010) Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration. Front Aging Neurosci 2. https:\/\/doi.org\/10.3389\/fnagi.2010.00025","DOI":"10.3389\/fnagi.2010.00025"},{"issue":"1","key":"2335_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/jad-2011-110614","volume":"28","author":"JJ Gallagher","year":"2012","unstructured":"Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA (2012) Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J Alzheimers Dis 28(1):147\u2013161. https:\/\/doi.org\/10.3233\/jad-2011-110614","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2335_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2014.07.006","volume":"36","author":"S van Rooden","year":"2015","unstructured":"van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P et al (2015) 7TT2*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease. Neurobiol Aging 36(1):20\u201326. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.006","journal-title":"Neurobiol Aging"},{"issue":"7","key":"2335_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1460-9568.2009.06701.x","volume":"29","author":"T Rival","year":"2009","unstructured":"Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, Liu B, Lewis H, Rosahl T et al (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 29(7):1335\u20131347. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.06701.x","journal-title":"Eur J Neurosci"},{"issue":"11","key":"2335_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5(11):863\u2013873. https:\/\/doi.org\/10.1038\/nrn1537","journal-title":"Nat Rev Neurosci"},{"key":"2335_CR15","doi-asserted-by":"publisher","unstructured":"Kim AC, Lim S, Kim YK (2018) Metal ion effects on A\u03b2 and Tau aggregation. Int J Mol Sci 19(1). https:\/\/doi.org\/10.3390\/ijms19010128","DOI":"10.3390\/ijms19010128"},{"issue":"6","key":"2335_CR16","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","volume":"286","author":"B Liu","year":"2011","unstructured":"Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ et al (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 286(6):4248\u20134256. https:\/\/doi.org\/10.1074\/jbc.M110.158980","journal-title":"J Biol Chem"},{"issue":"4","key":"2335_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/s0891-5849(00)00494-9","volume":"30","author":"CA Rottkamp","year":"2001","unstructured":"Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G et al (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30(4):447\u2013450. https:\/\/doi.org\/10.1016\/s0891-5849(00)00494-9","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2335_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/a:1020731021276","volume":"16","author":"G Perry","year":"2003","unstructured":"Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PL, Siedlak SL, Cash AD, Liu Q et al (2003) Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16(1):77\u201381. https:\/\/doi.org\/10.1023\/a:1020731021276","journal-title":"Biometals"},{"key":"2335_CR19","doi-asserted-by":"publisher","first-page":"726954","DOI":"10.1155\/2013\/726954","volume":"2013","author":"O Myhre","year":"2013","unstructured":"Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T (2013) Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures. Oxidative Med Cell Longev 2013:726954\u2013726919. https:\/\/doi.org\/10.1155\/2013\/726954","journal-title":"Oxidative Med Cell Longev"},{"issue":"Suppl 1","key":"2335_CR20","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.3233\/jad-2012-129011","volume":"33","author":"AI Bush","year":"2013","unstructured":"Bush AI (2013) The metal theory of Alzheimer's disease. J Alzheimers Dis 33(Suppl 1):S277\u2013S281. https:\/\/doi.org\/10.3233\/jad-2012-129011","journal-title":"J Alzheimers Dis"},{"issue":"5a","key":"2335_CR21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/j.1582-4934.2008.00356.x","volume":"12","author":"L Silvestri","year":"2008","unstructured":"Silvestri L, Camaschella C (2008) A potential pathogenetic role of iron in Alzheimer's disease. J Cell Mol Med 12(5a):1548\u20131550. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00356.x","journal-title":"J Cell Mol Med"},{"issue":"10","key":"2335_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060. https:\/\/doi.org\/10.1016\/s1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"issue":"4","key":"2335_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/jad-2009-1010","volume":"16","author":"S Altamura","year":"2009","unstructured":"Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimers Dis 16(4):879\u2013895. https:\/\/doi.org\/10.3233\/jad-2009-1010","journal-title":"J Alzheimers Dis"},{"key":"2335_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fnins.2018.00632","volume":"12","author":"JL Liu","year":"2018","unstructured":"Liu JL, Fan YG, Yang ZS, Wang ZY, Guo C (2018) Iron and Alzheimer's disease: from pathogenesis to therapeutic implications. Front Neurosci 12:632. https:\/\/doi.org\/10.3389\/fnins.2018.00632","journal-title":"Front Neurosci"},{"issue":"2","key":"2335_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5717\/jenb.2014.18.2.225","volume":"18","author":"DH Choi","year":"2014","unstructured":"Choi DH, Kwon IS, Koo JH, Jang YC, Kang EB, Byun JE, Um HS, Park HS et al (2014) The effect of treadmill exercise on inflammatory responses in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. J Exerc Nutr Biochem 18(2):225\u2013233. https:\/\/doi.org\/10.5717\/jenb.2014.18.2.225","journal-title":"J Exerc Nutr Biochem"},{"issue":"11","key":"2335_CR26","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s10495-013-0884-9","volume":"18","author":"EB Kang","year":"2013","unstructured":"Kang EB, Kwon IS, Koo JH, Kim EJ, Kim CH, Lee J, Yang CH, Lee YI et al (2013) Treadmill exercise represses neuronal cell death and inflammation during A\u03b2-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice. Apoptosis 18(11):1332\u20131347. https:\/\/doi.org\/10.1007\/s10495-013-0884-9","journal-title":"Apoptosis"},{"key":"2335_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.expneurol.2016.11.014","volume":"288","author":"JH Koo","year":"2017","unstructured":"Koo JH, Kang EB, Oh YS, Yang DS, Cho JY (2017) Treadmill exercise decreases amyloid-\u03b2 burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer's disease. Exp Neurol 288:142\u2013152. https:\/\/doi.org\/10.1016\/j.expneurol.2016.11.014","journal-title":"Exp Neurol"},{"issue":"4","key":"2335_CR28","first-page":"529","volume":"22","author":"HS Um","year":"2008","unstructured":"Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, Hwang DY, Cho JY (2008) Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE\/APPsw-transgenic model. Int J Mol Med 22(4):529\u2013539","journal-title":"Int J Mol Med"},{"issue":"11","key":"2335_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/0264041031000140365","volume":"21","author":"JY Cho","year":"2003","unstructured":"Cho JY, Hwang DY, Kang TS, Shin DH, Hwang JH, Lim CH, Lee SH, Lim HJ et al (2003) Use of NSE\/PS2m-transgenic mice in the study of the protective effect of exercise on Alzheimer's disease. J Sports Sci 21(11):943\u2013951. https:\/\/doi.org\/10.1080\/0264041031000140365","journal-title":"J Sports Sci"},{"issue":"3","key":"2335_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0531-5565(95)02032-2","volume":"31","author":"V Schefer","year":"1996","unstructured":"Schefer V, Talan MI (1996) Oxygen consumption in adult and AGED C57BL\/6J mice during acute treadmill exercise of different intensity. Exp Gerontol 31(3):387\u2013392. https:\/\/doi.org\/10.1016\/0531-5565(95)02032-2","journal-title":"Exp Gerontol"},{"issue":"10","key":"2335_CR31","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.neurobiolaging.2014.04.019","volume":"35","author":"J Becerril-Ortega","year":"2014","unstructured":"Becerril-Ortega J, Bordji K, Fr\u00e9ret T, Rush T, Buisson A (2014) Iron overload accelerates neuronal amyloid-\u03b2 production and cognitive impairment in transgenic mice model of Alzheimer's disease. Neurobiol Aging 35(10):2288\u20132301. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.04.019","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2335_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jagp.2018.10.008","volume":"27","author":"R Yu","year":"2019","unstructured":"Yu R, Topiwala A, Jacoby R, Fazel S (2019) Aggressive behaviors in Alzheimer disease and mild cognitive impairment: systematic review and meta-analysis. Am J Geriatr Psychiatry 27(3):290\u2013300. https:\/\/doi.org\/10.1016\/j.jagp.2018.10.008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"2335_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jmri.20244","volume":"21","author":"PA Hardy","year":"2005","unstructured":"Hardy PA, Gash D, Yokel R, Andersen A, Ai Y, Zhang Z (2005) Correlation of R2 with total iron concentration in the brains of rhesus monkeys. J Magn Reson Imaging 21(2):118\u2013127. https:\/\/doi.org\/10.1002\/jmri.20244","journal-title":"J Magn Reson Imaging"},{"key":"2335_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jtemb.2014.11.009","volume":"30","author":"D Xian-hui","year":"2015","unstructured":"Xian-hui D, Wei-juan G, Tie-mei S, Hong-lin X, Jiang-tao B, Jing-yi Z, Xi-qing C (2015) Age-related changes of brain iron load changes in the frontal cortex in APPswe\/PS1\u0394E9 transgenic mouse model of Alzheimer's disease. J Trace Elem Med Biol 30:118\u2013123. https:\/\/doi.org\/10.1016\/j.jtemb.2014.11.009","journal-title":"J Trace Elem Med Biol"},{"key":"2335_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139 Suppl 1","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. J Neurochem 139 Suppl 1:179\u2013197. https:\/\/doi.org\/10.1111\/jnc.13425","journal-title":"J Neurochem"},{"issue":"5","key":"2335_CR36","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/j.1471-4159.2007.04976.x","volume":"103","author":"T Moos","year":"2007","unstructured":"Moos T, Rosengren Nielsen T, Skj\u00f8rringe T, Morgan EH (2007) Iron trafficking inside the brain. J Neurochem 103(5):1730\u20131740. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04976.x","journal-title":"J Neurochem"},{"key":"2335_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnagi.2018.00065","volume":"10","author":"A Ashraf","year":"2018","unstructured":"Ashraf A, Clark M, So PW (2018) The Aging of Iron Man. Front Aging Neurosci 10:65. https:\/\/doi.org\/10.3389\/fnagi.2018.00065","journal-title":"Front Aging Neurosci"},{"issue":"1-2","key":"2335_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/s0006-8993(98)00002-x","volume":"788","author":"MA Smith","year":"1998","unstructured":"Smith MA, Wehr K, Harris PL, Siedlak SL, Connor JR, Perry G (1998) Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 788(1-2):232\u2013236. https:\/\/doi.org\/10.1016\/s0006-8993(98)00002-x","journal-title":"Brain Res"},{"issue":"6","key":"2335_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrd.2016.248","volume":"16","author":"BJ Crielaard","year":"2017","unstructured":"Crielaard BJ, Lammers T, Rivella S (2017) Targeting iron metabolism in drug discovery and delivery. Nat Rev Drug Discov 16(6):400\u2013423. https:\/\/doi.org\/10.1038\/nrd.2016.248","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2335_CR40","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1007\/s12035-016-0067-0","volume":"54","author":"LN Lu","year":"2017","unstructured":"Lu LN, Qian ZM, Wu KC, Yung WH, Ke Y (2017) Expression of Iron transporters and pathological hallmarks of Parkinson's and Alzheimer's Diseases in the brain of young, adult, and aged rats. Mol Neurobiol 54(7):5213\u20135224. https:\/\/doi.org\/10.1007\/s12035-016-0067-0","journal-title":"Mol Neurobiol"},{"issue":"1-2","key":"2335_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.07.005","volume":"77","author":"H Yang","year":"2013","unstructured":"Yang H, Yang M, Guan H, Liu Z, Zhao S, Takeuchi S, Yanagisawa D, Tooyama I (2013) Mitochondrial ferritin in neurodegenerative diseases. Neurosci Res 77(1-2):1\u20137. https:\/\/doi.org\/10.1016\/j.neures.2013.07.005","journal-title":"Neurosci Res"},{"issue":"7","key":"2335_CR42","doi-asserted-by":"publisher","first-page":"e22325","DOI":"10.1371\/journal.pone.0022325","volume":"6","author":"L Wang","year":"2011","unstructured":"Wang L, Yang H, Zhao S, Sato H, Konishi Y, Beach TG, Abdelalim EM, Bisem NJ et al (2011) Expression and localization of mitochondrial ferritin mRNA in Alzheimer's disease cerebral cortex. PLoS One 6(7):e22325. https:\/\/doi.org\/10.1371\/journal.pone.0022325","journal-title":"PLoS One"},{"issue":"2","key":"2335_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/ars.2011.4285","volume":"18","author":"WS Wu","year":"2013","unstructured":"Wu WS, Zhao YS, Shi ZH, Chang SY, Nie GJ, Duan XL, Zhao SM, Wu Q et al (2013) Mitochondrial ferritin attenuates \u03b2-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk\/P38 mitogen-activated protein kinase pathways. Antioxid Redox Signal 18(2):158\u2013169. https:\/\/doi.org\/10.1089\/ars.2011.4285","journal-title":"Antioxid Redox Signal"},{"key":"2335_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fphar.2014.00019","volume":"5","author":"G Gao","year":"2014","unstructured":"Gao G, Chang YZ (2014) Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases. Front Pharmacol 5:19. https:\/\/doi.org\/10.3389\/fphar.2014.00019","journal-title":"Front Pharmacol"},{"key":"2335_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.actbio.2017.10.039","volume":"65","author":"D Wang","year":"2018","unstructured":"Wang D, Zhang Q, Hu X, Wang W, Zhu X, Yuan Z (2018) Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid \u03b2-Cu fibrils. Acta Biomater 65:327\u2013338. https:\/\/doi.org\/10.1016\/j.actbio.2017.10.039","journal-title":"Acta Biomater"},{"issue":"2","key":"2335_CR46","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.bbrc.2006.08.077","volume":"349","author":"EM Hwang","year":"2006","unstructured":"Hwang EM, Kim SK, Sohn JH, Lee JY, Kim Y, Kim YS, Mook-Jung I (2006) Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochem Biophys Res Commun 349(2):654\u2013659. https:\/\/doi.org\/10.1016\/j.bbrc.2006.08.077","journal-title":"Biochem Biophys Res Commun"},{"issue":"2-3","key":"2335_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000065696","volume":"24","author":"GM Bishop","year":"2002","unstructured":"Bishop GM, Robinson SR, Liu Q, Perry G, Atwood CS, Smith MA (2002) Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24(2-3):184\u2013187. https:\/\/doi.org\/10.1159\/000065696","journal-title":"Dev Neurosci"},{"issue":"5","key":"2335_CR48","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1471-4159.2007.05127.x","volume":"104","author":"Y Tachida","year":"2008","unstructured":"Tachida Y, Nakagawa K, Saito T, Saido TC, Honda T, Saito Y, Murayama S, Endo T et al (2008) Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. J Neurochem 104(5):1387\u20131393. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05127.x","journal-title":"J Neurochem"},{"issue":"2","key":"2335_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12640-012-9373-0","volume":"24","author":"LC Souza","year":"2013","unstructured":"Souza LC, Filho CB, Goes AT, Fabbro LD, de Gomes MG, Savegnago L, Oliveira MS, Jesse CR (2013) Neuroprotective effect of physical exercise in a mouse model of Alzheimer's disease induced by \u03b2-amyloid1-40 peptide. Neurotox Res 24(2):148\u2013163. https:\/\/doi.org\/10.1007\/s12640-012-9373-0","journal-title":"Neurotox Res"},{"key":"2335_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2014.00038","volume":"5","author":"PJ Urrutia","year":"2014","unstructured":"Urrutia PJ, Mena NP, N\u00fa\u00f1ez MT (2014) The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol 5:38. https:\/\/doi.org\/10.3389\/fphar.2014.00038","journal-title":"Front Pharmacol"},{"issue":"5-6","key":"2335_CR51","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1159\/000188336","volume":"29","author":"Y Pan","year":"2012","unstructured":"Pan Y, Chen Y, Yu X, Wang J, Zhang L, He Y, Zheng Y, Zheng J (2012) The synthesis of a novel chalcone and evaluation for anti-free radical activity and antagonizing the learning impairments in Alzheimer's model. Cell Physiol Biochem 29(5-6):949\u2013958. https:\/\/doi.org\/10.1159\/000188336","journal-title":"Cell Physiol Biochem"},{"key":"2335_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2014.02.002","volume":"264","author":"PX Xu","year":"2014","unstructured":"Xu PX, Wang SW, Yu XL, Su YJ, Wang T, Zhou WW, Zhang H, Wang YJ et al (2014) Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing A\u03b2 oligomer level and attenuating oxidative stress and neuroinflammation. Behav Brain Res 264:173\u2013180. https:\/\/doi.org\/10.1016\/j.bbr.2014.02.002","journal-title":"Behav Brain Res"},{"issue":"2","key":"2335_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neures.2010.10.004","volume":"69","author":"HS Um","year":"2011","unstructured":"Um HS, Kang EB, Koo JH, Kim HT, Jin L, Kim EJ, Yang CH, An GY et al (2011) Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neurosci Res 69(2):161\u2013173. https:\/\/doi.org\/10.1016\/j.neures.2010.10.004","journal-title":"Neurosci Res"},{"issue":"6","key":"2335_CR54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/ars.2009.3018","volume":"13","author":"ZH Shi","year":"2010","unstructured":"Shi ZH, Nie G, Duan XL, Rouault T, Wu WS, Ning B, Zhang N, Chang YZ et al (2010) Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease. Antioxid Redox Signal 13(6):783\u2013796. https:\/\/doi.org\/10.1089\/ars.2009.3018","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"2335_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"2335_CR56","doi-asserted-by":"publisher","first-page":"e0190205","DOI":"10.1371\/journal.pone.0190205","volume":"13","author":"K Do","year":"2018","unstructured":"Do K, Laing BT, Landry T, Bunner W, Mersaud N, Matsubara T, Li P, Yuan Y et al (2018) The effects of exercise on hypothalamic neurodegeneration of Alzheimer's disease mouse model. PLoS One 13(1):e0190205. https:\/\/doi.org\/10.1371\/journal.pone.0190205","journal-title":"PLoS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02335-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02335-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02335-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:44:59Z","timestamp":1625496299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02335-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02335-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of Korea National Sport University and by the Korea Food and Drug Administration (FDA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}